David J Mauro insider trades

Open-market stock purchases and sales by David J Mauro, Chief Medical Officer at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 20, 2014.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • RXRX Recursion Pharmaceuticals, Inc: other filings, last Nov 15, 2024
  • CDAK Codiak BioSciences, Inc: other filings, last Jan 24, 2023
  • PRLD Prelude Therapeutics Inc: 30 sales, last Oct 5, 2021
  • ADXS Advaxis, Inc: 1 sale, last Dec 31, 2015

Get free alerts when David J Mauro files a new trade →